Estradiol Transdermal Patches Market Comprehensive Insight by Growth Rate, Industry Status, Forecast till 2027
The global estradiol transdermal patches market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Estradiol is a form of estrogen which is a female sex hormone produced by the ovaries necessary for many processes in the body. Additionally, estradiol transdermal patches are used for the treatment of certain symptoms of menopause such as hot flashes, vaginal dryness, burning, and irritation. The major factor driving the demand for estradiol transdermal patches is the new product launches and drug approval across the globe.
For instance, in December 2020,
Agile Therapeutics, Inc. announced the launch of the Twirla (levonorgestrel and
Ethinyl estradiol) transdermal system in the US. It is a non-daily,
non-invasive contraceptive patch available by prescription for women of
reproductive potential with a body mass index (BMI) <30 kg/m2 for whom a
combined hormonal contraceptive is appropriate to prevent pregnancy.
Furthermore, the market is also growing due to the increasing application of
these patches in males and females for treatment.
To Request a Sample of our Report on Estradiol
Transdermal Patches Market: https://www.omrglobal.com/request-sample/estradiol-transdermal-patches-market
Some major players in the market include Novartis
International AG, Bayer AG, and Johnson & Johnson Services, Inc., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in February
2021, Amneal Pharmaceuticals, Inc. announced the approval of Abbreviated New
Drug Application (ANDA) for 150 mcg/day Norelgestromin and 35 mcg/day Ethinyl
Estradiol Transdermal System from the US Food and Drug Administration (FDA).
Additionally, the company also received a Competitive Generic Therapy (CGT) designation
with 180 days of exclusivity.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Novartis International AG,
Bayer AG, and Johnson & Johnson Services, Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Estradiol Transdermal Patches Market is Available @ https://www.omrglobal.com/industry-reports/estradiol-transdermal-patches-market
Global Estradiol Transdermal Patches Market Report by
Segment
By Type
·
25 mg/day
·
50 mg/day
·
75 mg/day
·
100 mg/day
By Application
·
Male
·
Female
Global Estradiol Transdermal Patches Market Report by
Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment